SEATTLE (AP) — SEATTLE (AP) — Neoleukin Therapeutics, Inc. (NLTX) on Tuesday reported a loss of $4.5 million in its third quarter.
On a per-share basis, the Seattle-based company said it had a loss of 41 cents.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NLTX at https://www.zacks.com/ap/NLTX
